Baidu
map
MOL CELL ENDOCRINOL 润色咨询

MOLECULAR AND CELLULAR ENDOCRINOLOGY

出版年份:1974 年文章数:4403 投稿命中率: 开通期刊会员,数据随心看

出版周期:Semimonthly 自引率:3.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2157747, encodeId=d83f215e74701, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:生殖内分泌<br>经验分享:editor喜欢给 conditional rejected,但是又可以revise回去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Thu Sep 14 22:09:30 CST 2023, time=2023-09-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131158, encodeId=dea32131158f8, content=请问这个杂志只能有一个通讯作者吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97481704305, createdName=IWNMY, createdTime=Tue May 09 15:22:37 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1095121, encodeId=72e0109512131, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095122, encodeId=7a151095122cd, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893376, encodeId=d5128933e6f1, content=非常专业的杂志,要求研究做的较深。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Oct 20 20:10:11 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578683, encodeId=3aad5e868302, content=继续努力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854239, encodeId=809f854239ea, content=评审挺专业的,估计是内容不符吧,被拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Sun Oct 13 14:41:18 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574991, encodeId=64615e49913e, content=请问你的文章投稿后就好送外审的?^_^<span class="quote">189P3xP8469(暂无昵称) 2019-01-11 发表::<br>2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收</span><span class="quote">189P3xP8469(暂无昵称) 2019-01-11 00:00:00 发表:<br>2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收</span>, beContent=189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46cc2404186, createdName=颠疯, createdTime=Mon Aug 19 00:00:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565437, encodeId=b12456543e83, content=2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5232388566, createdName=1232bc4bm69(暂无昵称), createdTime=Fri Jan 11 00:00:00 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560767, encodeId=b440560e67f2, content=最近刚接收一篇,大修了几十个问题,这杂志对文章还是要求挺高的,偏重基础和创新,希望自己再接再厉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc831640055, createdName=marwin, createdTime=Wed Sep 05 19:57:00 CST 2018, time=2018-09-05, status=1, ipAttribution=)]
    2023-09-14 632005764 来自江苏省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:生殖内分泌
    经验分享:editor喜欢给 conditional rejected,但是又可以revise回去。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2157747, encodeId=d83f215e74701, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:生殖内分泌<br>经验分享:editor喜欢给 conditional rejected,但是又可以revise回去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Thu Sep 14 22:09:30 CST 2023, time=2023-09-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131158, encodeId=dea32131158f8, content=请问这个杂志只能有一个通讯作者吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97481704305, createdName=IWNMY, createdTime=Tue May 09 15:22:37 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1095121, encodeId=72e0109512131, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095122, encodeId=7a151095122cd, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893376, encodeId=d5128933e6f1, content=非常专业的杂志,要求研究做的较深。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Oct 20 20:10:11 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578683, encodeId=3aad5e868302, content=继续努力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854239, encodeId=809f854239ea, content=评审挺专业的,估计是内容不符吧,被拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Sun Oct 13 14:41:18 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574991, encodeId=64615e49913e, content=请问你的文章投稿后就好送外审的?^_^<span class="quote">189P3xP8469(暂无昵称) 2019-01-11 发表::<br>2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收</span><span class="quote">189P3xP8469(暂无昵称) 2019-01-11 00:00:00 发表:<br>2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收</span>, beContent=189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46cc2404186, createdName=颠疯, createdTime=Mon Aug 19 00:00:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565437, encodeId=b12456543e83, content=2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5232388566, createdName=1232bc4bm69(暂无昵称), createdTime=Fri Jan 11 00:00:00 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560767, encodeId=b440560e67f2, content=最近刚接收一篇,大修了几十个问题,这杂志对文章还是要求挺高的,偏重基础和创新,希望自己再接再厉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc831640055, createdName=marwin, createdTime=Wed Sep 05 19:57:00 CST 2018, time=2018-09-05, status=1, ipAttribution=)]
    2023-05-09 IWNMY 来自江苏省

    请问这个杂志只能有一个通讯作者吗?

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2157747, encodeId=d83f215e74701, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:生殖内分泌<br>经验分享:editor喜欢给 conditional rejected,但是又可以revise回去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Thu Sep 14 22:09:30 CST 2023, time=2023-09-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131158, encodeId=dea32131158f8, content=请问这个杂志只能有一个通讯作者吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97481704305, createdName=IWNMY, createdTime=Tue May 09 15:22:37 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1095121, encodeId=72e0109512131, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095122, encodeId=7a151095122cd, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893376, encodeId=d5128933e6f1, content=非常专业的杂志,要求研究做的较深。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Oct 20 20:10:11 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578683, encodeId=3aad5e868302, content=继续努力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854239, encodeId=809f854239ea, content=评审挺专业的,估计是内容不符吧,被拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Sun Oct 13 14:41:18 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574991, encodeId=64615e49913e, content=请问你的文章投稿后就好送外审的?^_^<span class="quote">189P3xP8469(暂无昵称) 2019-01-11 发表::<br>2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收</span><span class="quote">189P3xP8469(暂无昵称) 2019-01-11 00:00:00 发表:<br>2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收</span>, beContent=189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46cc2404186, createdName=颠疯, createdTime=Mon Aug 19 00:00:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565437, encodeId=b12456543e83, content=2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5232388566, createdName=1232bc4bm69(暂无昵称), createdTime=Fri Jan 11 00:00:00 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560767, encodeId=b440560e67f2, content=最近刚接收一篇,大修了几十个问题,这杂志对文章还是要求挺高的,偏重基础和创新,希望自己再接再厉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc831640055, createdName=marwin, createdTime=Wed Sep 05 19:57:00 CST 2018, time=2018-09-05, status=1, ipAttribution=)]
    2021-12-29 桑晒麦拉

    期刊可以有几个通讯作者/第一作者?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2157747, encodeId=d83f215e74701, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:生殖内分泌<br>经验分享:editor喜欢给 conditional rejected,但是又可以revise回去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Thu Sep 14 22:09:30 CST 2023, time=2023-09-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131158, encodeId=dea32131158f8, content=请问这个杂志只能有一个通讯作者吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97481704305, createdName=IWNMY, createdTime=Tue May 09 15:22:37 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1095121, encodeId=72e0109512131, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095122, encodeId=7a151095122cd, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893376, encodeId=d5128933e6f1, content=非常专业的杂志,要求研究做的较深。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Oct 20 20:10:11 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578683, encodeId=3aad5e868302, content=继续努力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854239, encodeId=809f854239ea, content=评审挺专业的,估计是内容不符吧,被拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Sun Oct 13 14:41:18 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574991, encodeId=64615e49913e, content=请问你的文章投稿后就好送外审的?^_^<span class="quote">189P3xP8469(暂无昵称) 2019-01-11 发表::<br>2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收</span><span class="quote">189P3xP8469(暂无昵称) 2019-01-11 00:00:00 发表:<br>2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收</span>, beContent=189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46cc2404186, createdName=颠疯, createdTime=Mon Aug 19 00:00:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565437, encodeId=b12456543e83, content=2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5232388566, createdName=1232bc4bm69(暂无昵称), createdTime=Fri Jan 11 00:00:00 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560767, encodeId=b440560e67f2, content=最近刚接收一篇,大修了几十个问题,这杂志对文章还是要求挺高的,偏重基础和创新,希望自己再接再厉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc831640055, createdName=marwin, createdTime=Wed Sep 05 19:57:00 CST 2018, time=2018-09-05, status=1, ipAttribution=)]
    2021-12-27 msSSSSSD

    所有作者在文章接收之后都会接收到邮件吗?

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2157747, encodeId=d83f215e74701, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:生殖内分泌<br>经验分享:editor喜欢给 conditional rejected,但是又可以revise回去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Thu Sep 14 22:09:30 CST 2023, time=2023-09-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131158, encodeId=dea32131158f8, content=请问这个杂志只能有一个通讯作者吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97481704305, createdName=IWNMY, createdTime=Tue May 09 15:22:37 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1095121, encodeId=72e0109512131, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095122, encodeId=7a151095122cd, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893376, encodeId=d5128933e6f1, content=非常专业的杂志,要求研究做的较深。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Oct 20 20:10:11 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578683, encodeId=3aad5e868302, content=继续努力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854239, encodeId=809f854239ea, content=评审挺专业的,估计是内容不符吧,被拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Sun Oct 13 14:41:18 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574991, encodeId=64615e49913e, content=请问你的文章投稿后就好送外审的?^_^<span class="quote">189P3xP8469(暂无昵称) 2019-01-11 发表::<br>2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收</span><span class="quote">189P3xP8469(暂无昵称) 2019-01-11 00:00:00 发表:<br>2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收</span>, beContent=189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46cc2404186, createdName=颠疯, createdTime=Mon Aug 19 00:00:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565437, encodeId=b12456543e83, content=2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5232388566, createdName=1232bc4bm69(暂无昵称), createdTime=Fri Jan 11 00:00:00 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560767, encodeId=b440560e67f2, content=最近刚接收一篇,大修了几十个问题,这杂志对文章还是要求挺高的,偏重基础和创新,希望自己再接再厉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc831640055, createdName=marwin, createdTime=Wed Sep 05 19:57:00 CST 2018, time=2018-09-05, status=1, ipAttribution=)]
    2020-10-20 zzzzfffvvv

    非常专业的杂志,要求研究做的较深。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2157747, encodeId=d83f215e74701, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:生殖内分泌<br>经验分享:editor喜欢给 conditional rejected,但是又可以revise回去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Thu Sep 14 22:09:30 CST 2023, time=2023-09-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131158, encodeId=dea32131158f8, content=请问这个杂志只能有一个通讯作者吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97481704305, createdName=IWNMY, createdTime=Tue May 09 15:22:37 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1095121, encodeId=72e0109512131, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095122, encodeId=7a151095122cd, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893376, encodeId=d5128933e6f1, content=非常专业的杂志,要求研究做的较深。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Oct 20 20:10:11 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578683, encodeId=3aad5e868302, content=继续努力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854239, encodeId=809f854239ea, content=评审挺专业的,估计是内容不符吧,被拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Sun Oct 13 14:41:18 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574991, encodeId=64615e49913e, content=请问你的文章投稿后就好送外审的?^_^<span class="quote">189P3xP8469(暂无昵称) 2019-01-11 发表::<br>2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收</span><span class="quote">189P3xP8469(暂无昵称) 2019-01-11 00:00:00 发表:<br>2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收</span>, beContent=189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46cc2404186, createdName=颠疯, createdTime=Mon Aug 19 00:00:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565437, encodeId=b12456543e83, content=2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5232388566, createdName=1232bc4bm69(暂无昵称), createdTime=Fri Jan 11 00:00:00 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560767, encodeId=b440560e67f2, content=最近刚接收一篇,大修了几十个问题,这杂志对文章还是要求挺高的,偏重基础和创新,希望自己再接再厉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc831640055, createdName=marwin, createdTime=Wed Sep 05 19:57:00 CST 2018, time=2018-09-05, status=1, ipAttribution=)]
    2019-10-25 147612bem32暂无昵称

    继续努力

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2157747, encodeId=d83f215e74701, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:生殖内分泌<br>经验分享:editor喜欢给 conditional rejected,但是又可以revise回去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Thu Sep 14 22:09:30 CST 2023, time=2023-09-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131158, encodeId=dea32131158f8, content=请问这个杂志只能有一个通讯作者吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97481704305, createdName=IWNMY, createdTime=Tue May 09 15:22:37 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1095121, encodeId=72e0109512131, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095122, encodeId=7a151095122cd, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893376, encodeId=d5128933e6f1, content=非常专业的杂志,要求研究做的较深。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Oct 20 20:10:11 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578683, encodeId=3aad5e868302, content=继续努力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854239, encodeId=809f854239ea, content=评审挺专业的,估计是内容不符吧,被拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Sun Oct 13 14:41:18 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574991, encodeId=64615e49913e, content=请问你的文章投稿后就好送外审的?^_^<span class="quote">189P3xP8469(暂无昵称) 2019-01-11 发表::<br>2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收</span><span class="quote">189P3xP8469(暂无昵称) 2019-01-11 00:00:00 发表:<br>2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收</span>, beContent=189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46cc2404186, createdName=颠疯, createdTime=Mon Aug 19 00:00:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565437, encodeId=b12456543e83, content=2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5232388566, createdName=1232bc4bm69(暂无昵称), createdTime=Fri Jan 11 00:00:00 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560767, encodeId=b440560e67f2, content=最近刚接收一篇,大修了几十个问题,这杂志对文章还是要求挺高的,偏重基础和创新,希望自己再接再厉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc831640055, createdName=marwin, createdTime=Wed Sep 05 19:57:00 CST 2018, time=2018-09-05, status=1, ipAttribution=)]
    2019-10-13 ms4039545388929122

    评审挺专业的,估计是内容不符吧,被拒了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2157747, encodeId=d83f215e74701, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:生殖内分泌<br>经验分享:editor喜欢给 conditional rejected,但是又可以revise回去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Thu Sep 14 22:09:30 CST 2023, time=2023-09-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131158, encodeId=dea32131158f8, content=请问这个杂志只能有一个通讯作者吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97481704305, createdName=IWNMY, createdTime=Tue May 09 15:22:37 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1095121, encodeId=72e0109512131, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095122, encodeId=7a151095122cd, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893376, encodeId=d5128933e6f1, content=非常专业的杂志,要求研究做的较深。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Oct 20 20:10:11 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578683, encodeId=3aad5e868302, content=继续努力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854239, encodeId=809f854239ea, content=评审挺专业的,估计是内容不符吧,被拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Sun Oct 13 14:41:18 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574991, encodeId=64615e49913e, content=请问你的文章投稿后就好送外审的?^_^<span class="quote">189P3xP8469(暂无昵称) 2019-01-11 发表::<br>2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收</span><span class="quote">189P3xP8469(暂无昵称) 2019-01-11 00:00:00 发表:<br>2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收</span>, beContent=189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46cc2404186, createdName=颠疯, createdTime=Mon Aug 19 00:00:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565437, encodeId=b12456543e83, content=2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5232388566, createdName=1232bc4bm69(暂无昵称), createdTime=Fri Jan 11 00:00:00 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560767, encodeId=b440560e67f2, content=最近刚接收一篇,大修了几十个问题,这杂志对文章还是要求挺高的,偏重基础和创新,希望自己再接再厉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc831640055, createdName=marwin, createdTime=Wed Sep 05 19:57:00 CST 2018, time=2018-09-05, status=1, ipAttribution=)]
    2019-08-19 颠疯

    请问你的文章投稿后就好送外审的?^_^189P3xP8469(暂无昵称) 2019-01-11 发表::
    2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收
    189P3xP8469(暂无昵称) 2019-01-11 00:00:00 发表:
    2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收

    189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2157747, encodeId=d83f215e74701, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:生殖内分泌<br>经验分享:editor喜欢给 conditional rejected,但是又可以revise回去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Thu Sep 14 22:09:30 CST 2023, time=2023-09-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131158, encodeId=dea32131158f8, content=请问这个杂志只能有一个通讯作者吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97481704305, createdName=IWNMY, createdTime=Tue May 09 15:22:37 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1095121, encodeId=72e0109512131, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095122, encodeId=7a151095122cd, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893376, encodeId=d5128933e6f1, content=非常专业的杂志,要求研究做的较深。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Oct 20 20:10:11 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578683, encodeId=3aad5e868302, content=继续努力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854239, encodeId=809f854239ea, content=评审挺专业的,估计是内容不符吧,被拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Sun Oct 13 14:41:18 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574991, encodeId=64615e49913e, content=请问你的文章投稿后就好送外审的?^_^<span class="quote">189P3xP8469(暂无昵称) 2019-01-11 发表::<br>2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收</span><span class="quote">189P3xP8469(暂无昵称) 2019-01-11 00:00:00 发表:<br>2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收</span>, beContent=189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46cc2404186, createdName=颠疯, createdTime=Mon Aug 19 00:00:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565437, encodeId=b12456543e83, content=2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5232388566, createdName=1232bc4bm69(暂无昵称), createdTime=Fri Jan 11 00:00:00 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560767, encodeId=b440560e67f2, content=最近刚接收一篇,大修了几十个问题,这杂志对文章还是要求挺高的,偏重基础和创新,希望自己再接再厉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc831640055, createdName=marwin, createdTime=Wed Sep 05 19:57:00 CST 2018, time=2018-09-05, status=1, ipAttribution=)]
    2019-01-11 1232bc4bm69(暂无昵称)

    2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2157747, encodeId=d83f215e74701, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:生殖内分泌<br>经验分享:editor喜欢给 conditional rejected,但是又可以revise回去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Thu Sep 14 22:09:30 CST 2023, time=2023-09-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131158, encodeId=dea32131158f8, content=请问这个杂志只能有一个通讯作者吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97481704305, createdName=IWNMY, createdTime=Tue May 09 15:22:37 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1095121, encodeId=72e0109512131, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095122, encodeId=7a151095122cd, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893376, encodeId=d5128933e6f1, content=非常专业的杂志,要求研究做的较深。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Oct 20 20:10:11 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578683, encodeId=3aad5e868302, content=继续努力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854239, encodeId=809f854239ea, content=评审挺专业的,估计是内容不符吧,被拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Sun Oct 13 14:41:18 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574991, encodeId=64615e49913e, content=请问你的文章投稿后就好送外审的?^_^<span class="quote">189P3xP8469(暂无昵称) 2019-01-11 发表::<br>2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收</span><span class="quote">189P3xP8469(暂无昵称) 2019-01-11 00:00:00 发表:<br>2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收</span>, beContent=189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46cc2404186, createdName=颠疯, createdTime=Mon Aug 19 00:00:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565437, encodeId=b12456543e83, content=2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5232388566, createdName=1232bc4bm69(暂无昵称), createdTime=Fri Jan 11 00:00:00 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560767, encodeId=b440560e67f2, content=最近刚接收一篇,大修了几十个问题,这杂志对文章还是要求挺高的,偏重基础和创新,希望自己再接再厉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc831640055, createdName=marwin, createdTime=Wed Sep 05 19:57:00 CST 2018, time=2018-09-05, status=1, ipAttribution=)]
    2018-09-05 marwin

    最近刚接收一篇,大修了几十个问题,这杂志对文章还是要求挺高的,偏重基础和创新,希望自己再接再厉。

    0

共71条页码: 1/8页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map